Table 2.
Caki-1 Cells Induce Elimination of CD56+CD16+ Cell Subset without Affecting CD56+ CD16- NK Cells*.
| Caki-1 Cells | ||||
| - | - | + | + | |
| CD56+CD16+ (%) | CD56+CD16- (%) | CD56+CD16+ (%) | CD56+CD16- (%) | |
| Case | ||||
| 1 | 14 | 9.4 | 5.83 | 12.6 |
| 2 | 7.9 | 7.6 | 7.6 | 8.4 |
| 3 | 12.5 | 10.8 | 0.9 | 7.7 |
| 4 | 9.4 | 8.5 | 2.3 | 10.2 |
| 5 | 4.8 | 8.4 | 0.9 | 10 |
| 6 | 1.4 | 7.9 | 0.0 | 2.8 |
| Mean ± SD | 8.3 ± 4.7 | 8.7 ± 1.1 | 2.8 ± 2.8† | 8.6 ± 3.3 |
Peripheral blood mononuclear cells were cultured in the presence of IL-2 as detailed in the Materials and Methods section before culture in the presence or absence of Caki-1 RCC cells.
t test: CD16+ versus CD16+/Caki-1, P = .02; CD16+/Caki-1 versus CD16-/Caki-1, P = .007; bolded numbers, statistically significant differences.